薬剤誘発性膵炎の1例
Muskan Shrestha1, Pratick Shrestha2, Adarsha Mahaseth3
1Manmohan Cardiothoracic Vascular and Transplant Center Kathmandu Nepal.
Clinical case reports
|January 26, 2026
まとめ
抗菌薬であるシプロフロキサシンは、まれに重篤な状態である薬剤誘発性膵炎(DIP)を引き起こす可能性があります。このまれな有害事象を有する患者では、薬の中止と支持療法により、急速な回復が得られました。
科学分野:
- 消化器病学; 薬理学; 内科学
背景:
- 薬剤誘発性膵炎(DIP)は、急性腹痛のまれではあるが重要な原因です。ニューキノロン系抗菌薬であるシプロフロキサシンに関連するDIPの症例は、例外的にまれです。
研究 の 目的:
- シプロフロキサシンによって引き起こされる薬剤誘発性膵炎(DIP)のまれな症例を報告すること。ニューキノロン系薬の治療中に腹痛を呈する患者においてDIPを考慮することの重要性を強調すること。
主な方法:
- 急性上腹部痛を呈した35歳女性の症例報告。診断ワークアップには、臨床検査(アミラーゼ、リパーゼ)および造影CTが含まれました。一般的な膵炎の原因(胆石、アルコールなど)の除外。Naranjo ScaleおよびBadalov Classificationを用いた因果関係評価。
主要な成果:
- 患者は下痢のためにシプロフロキサシンを自己処方してから3日後に重度の膵炎を発症しました。血清アミラーゼおよびリパーゼレベルの上昇、CTで急性間質性膵炎を確認しました。一般的な原因は除外され、シプロフロキサシンが原因物質であると特定されました。シプロフロキサシンの投与中止と支持療法により、4日以内に臨床的および生化学的な急速な改善が得られました。
結論:
- シプロフロキサシンは薬剤誘発性膵炎のまれな原因となる可能性があります。早期認識と原因薬の撤回は、良好な転帰のために不可欠です。この症例は、ニューキノロン系薬の治療中に急性腹痛を呈する患者においてDIPを考慮する必要があることを強調しています。
関連する概念動画
Pancreatic Juice and Secretion
2.9K
Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
2.9K
Acute Pancreatitis I: Introduction
1.2K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.2K
Chronic Pancreatitis I: Introduction
725
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
725
Chronic Pancreatitis II: Collaborative Care
349
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
349
Pharmacokinetics: Drug–Drug Interactions
428
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
428
Bioequivalence of Drugs: Drugs with Multiple Indications
156
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
156


